NEW YORK (360Dx) – Quest Diagnostics announced today that it has partnered with Thermo Fisher Scientific to offer the company's next-generation sequencing-based companion diagnostic panel for non-small cell lung cancer.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies.
This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.